Grant Number:	1R01CA084890-01 Interpret this number
Primary Investigator:	Coetzee, Gerhard
Organization:	University Of Southern California
Project Title:	Androgen Receptor and Prostate Cancer Risk in Chinese
Fiscal Year:	1999

A unique feature of prostate cancer is the prevalence of clinically latent lesions that do not pose a health threat, and yet are histologically indistinguishable from clinically important lesions. Identification of risk factors that predict advanced disease carries considerable public health significance. We, and others, have provided evidence that the CAG repeat polymorphism in the androgen receptor (AR) gene is associated with advanced prostate cancer risk in US whites. We propose here a combined epidemiologic/molecular study to evaluate the relationship between AR genotypes and prostate cancer risk, by assembling cases and controls among genetically homogeneous Chinese of Singapore, and by screening for somatic mutations in the AR gene. Cases (approximately 400) will be histologically diagnosed incident cases of prostate cancer, aged 45-74 years, occurring among housing estate residents of Singapore in the 6-year period between Jan. 1, 1993 and Dec. 31, 1998. Controls (an aged-matched random sample of 400 men) will be selected from members of the Singapore Cohort Study of Diet and Cancer, an NCI-funded, ongoing population-based cohort of 60,000 Chinese men and women, who are housing estate residents and aged 45-74 years at baseline. In the molecular component, the prevalence of AR somatic mutations in advanced tumors will be determined and characterized, to check whether the distribution of constitutional AR-CAG repeats of patients with somatic AR mutation-positive tumors differ from those with AR mutation-negative tumors. Although AR mutations were considered in the past to occur rarely in prostate tumors, new data indicate that it might occur quite frequently in advanced disease. The mutations so far analyzed, are often of the "gain-of-function" kind, and might contribute to the progression to hormone resistant disease. The main hypothesis to be tested is that shorter CAG alleles code for more active ARs that in turn increase advanced prostate cancer risk by increasing the rate of prostate somatic mutations among onco- and tumor suppressor genes, including the AR gene itself. Results from this study will enable the critical assessment of the role of the AR in prostate cancer predisposition and progression, and will allow the inclusion of the AR gene in a multigenic model of prostate cancer development.




Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
Authors: Buchanan G. , Ricciardelli C. , Harris J.M. , Prescott J. , Yu Z.C. , Jia L. , Butler L.M. , Marshall V.R. , Scher H.I. , Gerald W.L. , et al. .
Source: Cancer Research, 2007-10-15 00:00:00.0; 67(20), p. 10087-96.
PMID: 17942943
Related Citations

Androgen and anti-androgen treatment modulates androgen receptor activity and DJ-1 stability.
Authors: Pitkänen-Arsiola T. , Tillman J.E. , Gu G. , Yuan J. , Roberts R.L. , Wantroba M. , Coetzee G.A. , Cookson M.S. , Kasper S. .
Source: The Prostate, 2006-08-01 00:00:00.0; 66(11), p. 1177-93.
PMID: 16652386
Related Citations

Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.
Authors: Jia L. , Coetzee G.A. .
Source: Cancer Research, 2005-09-01 00:00:00.0; 65(17), p. 8003-8.
PMID: 16140973
Related Citations

The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus.
Authors: Kim J. , Jia L. , Stallcup M.R. , Coetzee G.A. .
Source: Journal Of Molecular Endocrinology, 2005 Feb; 34(1), p. 107-18.
PMID: 15691881
Related Citations

GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor.
Authors: Shen H.C. , Buchanan G. , Butler L.M. , Prescott J. , Henderson M. , Tilley W.D. , Coetzee G.A. .
Source: Biological Chemistry, 2005 Jan; 386(1), p. 69-74.
PMID: 15843149
Related Citations

The androgen receptor: unlocking the secrets of its unique transactivation domain.
Authors: Shen H.C. , Coetzee G.A. .
Source: Vitamins And Hormones, 2005; 71, p. 301-19.
PMID: 16112272
Related Citations

Prostate specific antigen gene regulation by androgen receptor.
Authors: Kim J. , Coetzee G.A. .
Source: Journal Of Cellular Biochemistry, 2004-10-01 00:00:00.0; 93(2), p. 233-41.
PMID: 15368351
Related Citations

PC-3 cells with enhanced androgen receptor signaling: a model for clonal selection in prostate cancer.
Authors: Buchanan G. , Craft P.S. , Yang M. , Cheong A. , Prescott J. , Jia L. , Coetzee G.A. , Tilley W.D. .
Source: The Prostate, 2004-09-01 00:00:00.0; 60(4), p. 352-66.
PMID: 15264248
Related Citations

Structural and functional consequences of glutamine tract variation in the androgen receptor.
Authors: Buchanan G. , Yang M. , Cheong A. , Harris J.M. , Irvine R.A. , Lambert P.F. , Moore N.L. , Raynor M. , Neufing P.J. , Coetzee G.A. , et al. .
Source: Human Molecular Genetics, 2004-08-15 00:00:00.0; 13(16), p. 1677-92.
EPub date: 2004-08-15 00:00:00.0.
PMID: 15198988
Related Citations

Androgen receptor signaling: mechanism of interleukin-6 inhibition.
Authors: Jia L. , Choong C.S. , Ricciardelli C. , Kim J. , Tilley W.D. , Coetzee G.A. .
Source: Cancer Research, 2004-04-01 00:00:00.0; 64(7), p. 2619-26.
PMID: 15059919
Related Citations

Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor.
Authors: Kim J. , Jia L. , Tilley W.D. , Coetzee G.A. .
Source: Nucleic Acids Research, 2003-12-01 00:00:00.0; 31(23), p. 6741-7.
PMID: 14627807
Related Citations

Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
Authors: Jia L. , Kim J. , Shen H. , Clark P.E. , Tilley W.D. , Coetzee G.A. .
Source: Molecular Cancer Research : Mcr, 2003 Mar; 1(5), p. 385-92.
PMID: 12651911
Related Citations

The androgen receptor CAG repeat and prostate cancer risk.
Authors: Clark P.E. , Irvine R.A. , Coetzee G.A. .
Source: Methods In Molecular Medicine, 2003; 81, p. 255-66.
PMID: 12725125
Related Citations

Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort.
Authors: Xue W.M. , Coetzee G.A. , Ross R.K. , Irvine R. , Kolonel L. , Henderson B.E. , Ingles S.A. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2001 Jun; 10(6), p. 575-9.
PMID: 11401905
Related Citations

Contribution of the androgen receptor to prostate cancer predisposition and progression.
Authors: Buchanan G. , Irvine R.A. , Coetzee G.A. , Tilley W.D. .
Source: Cancer Metastasis Reviews, 2001; 20(3-4), p. 207-23.
PMID: 12085963
Related Citations

Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.
Authors: Park J.J. , Irvine R.A. , Buchanan G. , Koh S.S. , Park J.M. , Tilley W.D. , Stallcup M.R. , Press M.F. , Coetzee G.A. .
Source: Cancer Research, 2000-11-01 00:00:00.0; 60(21), p. 5946-9.
PMID: 11085509
Related Citations